Sfoglia per RIVISTA
NEUROTHERAPEUTICS : THE JOURNAL OF THE AMERICAN SOCIETY FOR EXPERIMENTAL NEUROTHERAPEUTICS
Collezione ASL Torino 4

  

Items : 2

Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY). in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2023 Aug 23. doi: 10.1007/s13311-023-01415-y.

2023
AOU Città della Salute di Torino
ASL Torino 4

Chisari CG; Bianco A; Brescia Morra V; Calabrese M; Capone F; Cavalla P; Chiavazza C; Comi C; Danni M; Filippi M; Iaffaldano P; Lanzillo R; Lo Fermo S; Lucisano A; Lugaresi A; Lus G; Marfia GA; Marinelli F; Mirabella M; Moiola L; Perin C; Realmuto S; Toscano S; Trojano M; Vecchio D; Patti F;

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2020 Jan;17(1):200-207. doi: 10.1007/s13311-019-00776-7.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Torino 4

Costantini G; Sormani MP; Cavalla P; Sartori A; Laroni A; Frangiamore R; Gandoglia I; Petruzzo M; Lanzillo R; Mataluni G; Landi D; Mirabella M; Baroncini D; Nociti V; Cocco E; Lorefice L; Curti E; Bonavita S; Lavorgna L; Maniscalco GT; Signoriello E; Lus G; Cordioli C; Signori A; Iudicello M; Capra R; De Mercanti SF; Clerico M;